See All Slides - tctmd.com

Slides

Presentation TCT 2013

Trends in access site choice for PCI and influence on mortality - Observational data from the British Cardiovascular Intervention Society PCI database.

Presenter: Karim Ratib, Mamas Mamas, Adrian Large, Samer Arnous, Helen Routledge, Peter Ludman, Doug Fraser, Jim Nolan

January 31, 2013

Presentation ACVS 2012

Assessment of PVD and Indications for Interventions

Presenter: Sameer I. Dani

August 04, 2012

Presentation

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Presenter: Vivek Y. Reddy

January 29, 2013

Presentation Cell Therapy 2013

TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

Biologic Therapy For Claudication FIM Strategy

Presenter: Todd J. Brinton

January 22, 2013

Presentation Cell Therapy 2013

Targeting microRNAs: A Novel Option to Treat Cardiovascular Disease

Presenter: Stefanie Dimmeler

January 23, 2013

$Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up$

Presentation Cell Therapy 2013

Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up

Presenter: Anders Bruun Mathiasen

January 23, 2013

Presentation TCT 2012

For: Treating Bystander Disease in the Primary PCI Setting Increases Risk!

Presenter: Ran Kornowski

October 25, 2012

Presentation TCT 2012

Case Presentation Conclusion: Procedural and Patient Outcomes(2)

Presenter: Andreas Baumbach

October 25, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Advertisement

Slides

Trends in access site choice for PCI and influence on mortality - Observational data from the British Cardiovascular Intervention Society PCI database.

Assessment of PVD and Indications for Interventions

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI

Biologic Therapy For Claudication FIM Strategy

Targeting microRNAs: A Novel Option to Treat Cardiovascular Disease

Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up

For: Treating Bystander Disease in the Primary PCI Setting Increases Risk!

Case Presentation Conclusion: Procedural and Patient Outcomes(2)

Autologous Cardiac Stem Cells in VAD Patients

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content